PSLAX | SSGSX | PSLAX / SSGSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 26 years | 26 years | - |
Gain YTD | 9.994 | 9.331 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500 | 2500 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 290M | 6.96B | 4% |
Annual Yield % from dividends | 0.52 | 0.35 | 145% |
Returns for 1 year | 24.51 | 13.80 | 178% |
Returns for 3 years | 5.30 | -12.22 | -43% |
Returns for 5 years | 63.94 | 14.39 | 444% |
Returns for 10 years | 19.40 | 26.20 | 74% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
STRCX | 10.00 | N/A | N/A |
Sterling Capital Behavioral Intl Eq R6 | |||
FMIYX | 36.84 | -0.12 | -0.32% |
FMI International Institutional | |||
FOPTX | 19.87 | -0.13 | -0.65% |
Fidelity Advisor Intl Sm Cap Opps M | |||
WPOIX | 12.94 | -0.18 | -1.37% |
Weitz Partners III Opportunity Investor | |||
PHPIX | 26.83 | -1.12 | -4.01% |
ProFunds Pharmaceuticals UltraSector Inv |